Skip to content
  • Wednesday, 10 June 2026
  • 12:28 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Citius Oncology Secures Up to $36.5 Million in Debt and Equity Financing to Fuel Lymphir Commercialization
Pharmaceutical R&D

Citius Oncology Secures Up to $36.5 Million in Debt and Equity Financing to Fuel Lymphir Commercialization

Teuku Ryan May 7, 2026 0

Citius Oncology has successfully secured a significant financial infusion, totaling up to $36.5 million, through a strategic combination of debt…

Read More
Pharmaceutical R&D

Sidewinder Therapeutics Secures $137 Million in Series B Financing to Advance Bispecific Antibody-Drug Conjugate Pipeline

Teuku Ryan Apr 8, 2026 0

Sidewinder Therapeutics has announced the successful closure of a substantial $137 million Series B financing round, a significant development signaling…

Read More
The deadly outbreak at sea may offer clues to how Andes hantavirus spreads from human to humanA Hidden Housekeeping Gene Holds the Key to Enhanced Fruit Quality Without Compromising Plant GrowthScience News: Empowering Public Understanding of Science, Medicine, and Technology Since 1921Internal Cellular "Trade Winds" Discovered, Revolutionizing Understanding of Cell Movement and Disease
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
Optimizing spaCy for Production-Grade NLP: Advanced Techniques for Speed and AccuracyForests’ Ancient Carbon Cycle Disrupted by Pervasive Nitrogen Pollution, New Study RevealsTWiV 1292: Clinical update with Dr. Daniel GriffinCornell University Researchers Develop Breakthrough Nonhormonal Male Contraceptive Targeting Cellular Meiosis
YOU MAY HAVE MISSED
Data Science & Bioinformatics
Optimizing spaCy for Production-Grade NLP: Advanced Techniques for Speed and Accuracy
Evan Lee Salim Jun 6, 2026
Molecular & Cell Biology
Forests’ Ancient Carbon Cycle Disrupted by Pervasive Nitrogen Pollution, New Study Reveals
Angie Faith Jun 6, 2026
Microbiology & Immunology
TWiV 1292: Clinical update with Dr. Daniel Griffin
Lina Irawan Jun 6, 2026
Stem Cell & Regenerative Medicine
Cornell University Researchers Develop Breakthrough Nonhormonal Male Contraceptive Targeting Cellular Meiosis
Dwi Wanna Jun 6, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ